Cargando…

Correlation of plasma and neuroimaging biomarkers in Alzheimer's disease

Blood‐based phosphorylated tau (Ptau) 181 and 217 biomarkers are sensitive and specific for Alzheimer's disease. In this racial/ethnically diverse cohort study, participants were classified as biomarker positive (Ptau+) or negative (Ptau‐) based on Ptau 181 and 217 concentrations and as cogniti...

Descripción completa

Detalles Bibliográficos
Autores principales: Brickman, Adam M., Manly, Jennifer J., Honig, Lawrence S., Sanchez, Danurys, Reyes‐Dumeyer, Dolly, Lantigua, Rafael A., Vonsattel, Jean Paul, Teich, Andrew F., Kang, Min Suk, Dage, Jeffrey L., Mayeux, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082382/
https://www.ncbi.nlm.nih.gov/pubmed/35306760
http://dx.doi.org/10.1002/acn3.51529
_version_ 1784703192848662528
author Brickman, Adam M.
Manly, Jennifer J.
Honig, Lawrence S.
Sanchez, Danurys
Reyes‐Dumeyer, Dolly
Lantigua, Rafael A.
Vonsattel, Jean Paul
Teich, Andrew F.
Kang, Min Suk
Dage, Jeffrey L.
Mayeux, Richard
author_facet Brickman, Adam M.
Manly, Jennifer J.
Honig, Lawrence S.
Sanchez, Danurys
Reyes‐Dumeyer, Dolly
Lantigua, Rafael A.
Vonsattel, Jean Paul
Teich, Andrew F.
Kang, Min Suk
Dage, Jeffrey L.
Mayeux, Richard
author_sort Brickman, Adam M.
collection PubMed
description Blood‐based phosphorylated tau (Ptau) 181 and 217 biomarkers are sensitive and specific for Alzheimer's disease. In this racial/ethnically diverse cohort study, participants were classified as biomarker positive (Ptau+) or negative (Ptau‐) based on Ptau 181 and 217 concentrations and as cognitively impaired (Sym) or unimpaired (Asym). The four groups, Ptau‐/Asym, Ptau+/Asym, Ptau‐/Sym, and Ptau+/Sym, differed by age, APOE‐4 allele frequency, total tau, neurofilament light chain, and cortical thickness measured by MRI. Our results add to increasing evidence that plasma Ptau 181 and 217 concentrations are valid Alzheimer's disease biomarkers in diverse populations.
format Online
Article
Text
id pubmed-9082382
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-90823822022-05-16 Correlation of plasma and neuroimaging biomarkers in Alzheimer's disease Brickman, Adam M. Manly, Jennifer J. Honig, Lawrence S. Sanchez, Danurys Reyes‐Dumeyer, Dolly Lantigua, Rafael A. Vonsattel, Jean Paul Teich, Andrew F. Kang, Min Suk Dage, Jeffrey L. Mayeux, Richard Ann Clin Transl Neurol Brief Communications Blood‐based phosphorylated tau (Ptau) 181 and 217 biomarkers are sensitive and specific for Alzheimer's disease. In this racial/ethnically diverse cohort study, participants were classified as biomarker positive (Ptau+) or negative (Ptau‐) based on Ptau 181 and 217 concentrations and as cognitively impaired (Sym) or unimpaired (Asym). The four groups, Ptau‐/Asym, Ptau+/Asym, Ptau‐/Sym, and Ptau+/Sym, differed by age, APOE‐4 allele frequency, total tau, neurofilament light chain, and cortical thickness measured by MRI. Our results add to increasing evidence that plasma Ptau 181 and 217 concentrations are valid Alzheimer's disease biomarkers in diverse populations. John Wiley and Sons Inc. 2022-03-20 /pmc/articles/PMC9082382/ /pubmed/35306760 http://dx.doi.org/10.1002/acn3.51529 Text en © 2022 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Brief Communications
Brickman, Adam M.
Manly, Jennifer J.
Honig, Lawrence S.
Sanchez, Danurys
Reyes‐Dumeyer, Dolly
Lantigua, Rafael A.
Vonsattel, Jean Paul
Teich, Andrew F.
Kang, Min Suk
Dage, Jeffrey L.
Mayeux, Richard
Correlation of plasma and neuroimaging biomarkers in Alzheimer's disease
title Correlation of plasma and neuroimaging biomarkers in Alzheimer's disease
title_full Correlation of plasma and neuroimaging biomarkers in Alzheimer's disease
title_fullStr Correlation of plasma and neuroimaging biomarkers in Alzheimer's disease
title_full_unstemmed Correlation of plasma and neuroimaging biomarkers in Alzheimer's disease
title_short Correlation of plasma and neuroimaging biomarkers in Alzheimer's disease
title_sort correlation of plasma and neuroimaging biomarkers in alzheimer's disease
topic Brief Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082382/
https://www.ncbi.nlm.nih.gov/pubmed/35306760
http://dx.doi.org/10.1002/acn3.51529
work_keys_str_mv AT brickmanadamm correlationofplasmaandneuroimagingbiomarkersinalzheimersdisease
AT manlyjenniferj correlationofplasmaandneuroimagingbiomarkersinalzheimersdisease
AT honiglawrences correlationofplasmaandneuroimagingbiomarkersinalzheimersdisease
AT sanchezdanurys correlationofplasmaandneuroimagingbiomarkersinalzheimersdisease
AT reyesdumeyerdolly correlationofplasmaandneuroimagingbiomarkersinalzheimersdisease
AT lantiguarafaela correlationofplasmaandneuroimagingbiomarkersinalzheimersdisease
AT vonsatteljeanpaul correlationofplasmaandneuroimagingbiomarkersinalzheimersdisease
AT teichandrewf correlationofplasmaandneuroimagingbiomarkersinalzheimersdisease
AT kangminsuk correlationofplasmaandneuroimagingbiomarkersinalzheimersdisease
AT dagejeffreyl correlationofplasmaandneuroimagingbiomarkersinalzheimersdisease
AT mayeuxrichard correlationofplasmaandneuroimagingbiomarkersinalzheimersdisease